FindTrial
Sign In

Evaluate the Effect of Medha Vati Extra Power in Migraine

A clinical Study to Evaluate the Effect of Medha Vati Extra Power in Migraine: Prospective, open label, single arm study - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/111896
Enrollment
52
Registered
2026-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Patanjali Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed migraine as per ICHD-3 criteria (with or without aura). Subjects experiencing Equal to or more than 4 migraine days per month at baseline. Subjects willing to give informed consent.

Exclusion criteria

Exclusion criteria: Subjects with secondary headache disorders (e.g., due to infection, tumor, sinusitis, or other identifiable causes). Subjects who are diagnosed with unstable mental or psychiatric illness. Subjects with hepatic and renal failure or significant neurological disorders (e.g., epilepsy, stroke). Pregnancy or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Change in Monthly Migraine Days (MMD)Timepoint: from baseline (Day 1) to Day 90—

Secondary

MeasureTime frame
Changes in migraine-related disability, assessed using the Migraine Disability (MIDAS) AssessmentTimepoint: from baseline (Day 1) to day 90—

Countries

India

Contacts

Public ContactDr Rakesh Dehari

Patanjali Wellness

drrakeshdehari2007@gmail.com917879701499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026